LaraZimmermannMD

Neurocritical Care

Associate Professor

Dr. Zimmermann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Neurocritical Care, 2014 - 2016
University of California (San Francisco)Residency, Neurology, 2011 - 2014
Cedars-Sinai Medical CenterInternship, Internal Medicine, 2010 - 2011
David Geffen School of Medicine at UCLAClass of 2010

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial Start of enrollment: 2021 Dec 03
Recruiting
Phase 3
Roles: Contact

PubMed

27 citations
Functional interferometric diffusing wave spectroscopy of the human brain
Wenjun Zhou, Oybek Kholiqov, Jun Zhu, Mingjun Zhao, Lara Zimmermann
Science Advances. 2021-05-01
Correction to: Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products.
Renee Castillo, Alissa Chan, Steven Atallah, Katrina Derry, Mark Baje
Journal of Thrombosis and Thrombolysis. 2021-01-01
23 citations
Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products.
Renee Castillo, Alissa Chan, Steven Atallah, Katrina Derry, Mark Baje
Journal of Thrombosis and Thrombolysis. 2021-01-01

New Technology for Measuring Brain Blood Flow with LightApril 27th, 2018
Researchers Hope to Study Protein as an Intervention for Stroke PatientsOctober 21st, 2023